17-75758563-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM1

The NM_000154.2(GALK1):​c.830G>A​(p.Arg277Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,596,756 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R277W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

GALK1
NM_000154.2 missense

Scores

11
7
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 7.38

Publications

2 publications found
Variant links:
Genes affected
GALK1 (HGNC:4118): (galactokinase 1) Galactokinase is a major enzyme for the metabolism of galactose and its deficiency causes congenital cataracts during infancy and presenile cataracts in the adult population. [provided by RefSeq, Jul 2008]
GALK1 Gene-Disease associations (from GenCC):
  • galactokinase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_000154.2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALK1NM_000154.2 linkc.830G>A p.Arg277Gln missense_variant Exon 6 of 8 ENST00000588479.6 NP_000145.1
GALK1NM_001381985.1 linkc.830G>A p.Arg277Gln missense_variant Exon 6 of 9 NP_001368914.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALK1ENST00000588479.6 linkc.830G>A p.Arg277Gln missense_variant Exon 6 of 8 1 NM_000154.2 ENSP00000465930.1

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152220
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000453
AC:
10
AN:
220888
AF XY:
0.0000654
show subpopulations
Gnomad AFR exome
AF:
0.000523
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000174
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000166
AC:
24
AN:
1444418
Hom.:
0
Cov.:
34
AF XY:
0.0000167
AC XY:
12
AN XY:
718476
show subpopulations
African (AFR)
AF:
0.000389
AC:
13
AN:
33394
American (AMR)
AF:
0.00
AC:
0
AN:
44090
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25934
East Asian (EAS)
AF:
0.0000760
AC:
3
AN:
39472
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84892
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5706
European-Non Finnish (NFE)
AF:
0.00000361
AC:
4
AN:
1109398
Other (OTH)
AF:
0.0000667
AC:
4
AN:
59986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000853
AC:
13
AN:
152338
Hom.:
0
Cov.:
33
AF XY:
0.0000805
AC XY:
6
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41588
American (AMR)
AF:
0.0000654
AC:
1
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.556
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000489
Hom.:
0
Bravo
AF:
0.0000756
ESP6500AA
AF:
0.000464
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000667
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 05, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: GALK1 c.830G>A (p.Arg277Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.5e-05 in 220888 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in GALK1 causing Deficiency Of Galactokinase (4.5e-05 vs 0.0011), allowing no conclusion about variant significance. c.830G>A has been reported in the literature as a compound heterozygous genotype in at-least one individual affected with Deficiency Of Galactokinase (example, Doo Park_2007). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function (example, Doo Park_2007). The most pronounced variant effect results in approximately 10%-15% of normal GALK activity in vitro. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

Deficiency of galactokinase Uncertain:1
Mar 23, 2018
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.43
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.78
D;.;D
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Pathogenic
0.97
.;D;D
M_CAP
Pathogenic
0.60
D
MetaRNN
Uncertain
0.74
D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.2
H;.;H
PhyloP100
7.4
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-3.8
D;.;.
REVEL
Pathogenic
0.92
Sift
Uncertain
0.0090
D;.;.
Sift4G
Uncertain
0.0050
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.98
MVP
0.98
MPC
0.73
ClinPred
0.88
D
GERP RS
4.8
Varity_R
0.85
gMVP
0.92
Mutation Taster
=28/72
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370029131; hg19: chr17-73754644; API